Literature DB >> 9408191

Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats.

J B Salgueiro1, P Ardenghi, M Dias, M B Ferreira, I Izquierdo, J H Medina.   

Abstract

The naturally occurring flavonoids, chrysin (5,7-dihydroxyflavone) and apigenin (5,7,4'-trihydroxyflavone), and the synthetic compound, 6,3'-dinitroflavone have been recently reported to selectively bind with high affinity to the central benzodiazepine receptor, and to exert powerful anxiolytic and other benzodiazepine-like effects in rats. Their chemical analog, quercetin, shares none of these effects. In the present article we find that, in contrast to diazepam, chrysin, apigenin, and 6,3'-dinitroflavone have no amnestic effect on acquisition or retention of three different learning tasks (inhibitory avoidance, shuttle avoidance, and habituation to an open field), even when given at doses higher than those previously reported to be anxiolytic. Apigenin had a slight enhancing effect on training session performance and, when given posttraining, on test session retention, of crossing responses in the open field and hindered retention of inhibitory avoidance, and showed no anxiolytic action in an elevated plus maze. Unlike diazepam, none of these drugs had any analgesic effect in the tail-flick test. The data suggest that chrysin, apigenin, and 6,3'-dinitroflavoine, three flavonoids derivatives possessing anxioselective effects acting on central benzodiazepine receptors, may deserve clinical trials as anxiolytic agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9408191     DOI: 10.1016/s0091-3057(97)00054-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  18 in total

1.  Cannabis is more than simply delta(9)-tetrahydrocannabinol.

Authors:  Ethan B Russo; John M McPartland
Journal:  Psychopharmacology (Berl)       Date:  2002-12-19       Impact factor: 4.530

2.  Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

Authors:  Miroslav M Savić; Dragan I Obradović; Nenad D Ugresić; James M Cook; P V V S Sarma; Dubravko R Bokonjić
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

3.  Improving the oral bioavailability of beneficial polyphenols through designed synergies.

Authors:  Arjan Scheepens; Kee Tan; James W Paxton
Journal:  Genes Nutr       Date:  2009-10-20       Impact factor: 5.523

Review 4.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

5.  Zornia latifolia: a smart drug being adulterated by Stylosanthes guianensis.

Authors:  L Cornara; A P Fortuna-Perez; I Bruni; A Salis; G Damonte; B Borghesi; M Clericuzio
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

6.  Modulation of ionotropic GABA receptors by 6-methoxyflavanone and 6-methoxyflavone.

Authors:  Belinda J Hall; Nasiara Karim; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Neurochem Res       Date:  2013-09-29       Impact factor: 3.996

Review 7.  Use of Plant-Derived Natural Products in Sleep Disturbances.

Authors:  Diana Lelli; Livio Cortese; Claudio Pedone
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Flavonoid modulation of GABA(A) receptors.

Authors:  Jane R Hanrahan; Mary Chebib; Graham A R Johnston
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

9.  Neuroprotective and Antioxidant Enhancing Properties of Selective Equisetum Extracts.

Authors:  Denisa Batir-Marin; Monica Boev; Oana Cioanca; Cornelia Mircea; Ana Flavia Burlec; Galba Jean Beppe; Adrian Spac; Andreia Corciova; Lucian Hritcu; Monica Hancianu
Journal:  Molecules       Date:  2021-04-28       Impact factor: 4.411

10.  Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study.

Authors:  Suzanna M Zick; Benjamin D Wright; Ananda Sen; J Todd Arnedt
Journal:  BMC Complement Altern Med       Date:  2011-09-22       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.